Old Web
English
Sign In
Acemap
>
Paper
>
669. Twelve-Month Durability of Microbiota-Based Therapy RBX2660 for Prevention of Recurrent Clostridium difficile Infection
669. Twelve-Month Durability of Microbiota-Based Therapy RBX2660 for Prevention of Recurrent Clostridium difficile Infection
2019
Courtney Jones
Sarah Mische
Ken Blount
Bill Shannon
Keywords:
Clostridium
Intensive care medicine
Medicine
clostridium difficile
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]